Clinical Trial Update: Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on combining bendamustine with bortezomib for relapsed/refractory multiple myeloma, with Phase 1 and Phase 2 results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Treanda (Bendamustine)
• Velcade (bortezomib)

Snippet

Sponsor: Cephalon | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-17